Latest News about RPRX
Recent news which mentions RPRX
From Benzinga
This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation'
June 30, 2022
From Benzinga
Ipsen to acquire U.S.-based Epizyme for $247 million.
June 27, 2022
From MarketWatch
From Motley Fool
From Benzinga
From Benzinga
Executives Sell Around $325M Of 3 Stocks
May 24, 2022
From Benzinga
From Motley Fool
From Benzinga
Tickers
RPRX
From Motley Fool
From Benzinga
From Benzinga
Expedia And 3 Other Stocks Insiders Are Selling
March 31, 2022
From Benzinga
Looking Into Royalty Pharma's Return On Capital Employed
February 16, 2022
Tickers
RPRX
From Benzinga
Royalty Pharma plc (RPRX) Q4 2021 Earnings Call Transcript
February 15, 2022
Tickers
RPRX
From Motley Fool
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
February 15, 2022
From Benzinga
Earnings Scheduled For February 15, 2022
February 15, 2022
From Benzinga
From Benzinga
From InvestorPlace
2 Chamath Palihapitiya SPAC Deals Rumored: Will He Land The Year's First Deal Once Again?
January 09, 2022
From Benzinga
2 Warren Buffett Dividend Stocks to Buy Right Now
December 14, 2021
From Motley Fool
Jim Cramer Shares His Thoughts On Canadian Pacific Railway, Royalty Pharma And More
December 10, 2021
From Benzinga
BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, Orladeyo
November 22, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.